Behavioral Health Business December 31, 2025
The Drug Enforcement Administration (DEA) delivered providers of substance use disorder (SUD) care a year-end gift that officially extends telehealth prescribing flexibilities around controlled medications like methadone, naltrexone and buprenorphine through Dec. 2026.
While the extension has been anticipated since early November after a pending executive order was sent to the Office of Management and Budget hinting at the agency’s intention to extend the prescribing provisions, the DEA officially announced the news on Dec. 31.
Though the deadline for a final decision on the rule’s future was slated for today, some have criticized the government for allowing the decision-making to be left for the last minute, which “created avoidable uncertainty,” across the industry and “came within hours of expiration, placing...
Today's Sponsors
Today's Sponsor